Gene therapy of arthritis with TCR isolated from the inflamed paw

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 8140-8147

  Fujio, Keishi ^a   Okamoto, Akiko ^a   Araki, Yasuto ^a   Shoda, Hirofumi ^a   Tahara, Hiroyuki ^a   Tsuno, Nelson H ^a   Takahashi, Koki ^a   Kitamura, Toshio ^b   Yamamoto, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; IMMUNOGLOBULIN; INTERLEUKIN 17; INTERLEUKIN 17A; INTERLEUKIN 1BETA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR B47; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BLOOD LEVEL; BONE DESTRUCTION; CELL CLONE; CELL SELECTION; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE IDENTIFICATION; GENE THERAPY; IMMUNOGLOBULIN GENE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; T LYMPHOCYTE;

EID: 33751567024     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.8140     Document Type: Article

References (33)

1. Maini, R., E. W. St. Clair, F. Breedveld, D. Furst, J. Kalden, M. Weisman, J. Smolen, P. Emery, G. Harriman, M. Feldmann, and P. Lipsky. 1999. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354: 1932-1939.
2. Lipsky, P. E., D. M. van der Heijde, E. W. St. Clair, D. E. Furst, F. C. Breedveld, J. R. Kalden, J. S. Smolen, M. Weisman, P. Emery, M. Feldmann, et al. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N. Engl. J. Med. 343: 1594-1602.
3. Weinblatt, M. E., J. M. Kremer, A. D. Bankburst, K. J. Bulpitt, R. M. Fleischmann, R. I. Fox, C. G. Jackson, M. Lange, and D. J. Burge. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340: 253-259.
4. Keane, J., S. Gershon, R. P. Wise, E. Mirabile-Levens, J. Kasznica, W. D. Schwieterman, J. N. Siegel, and M. M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med 345: 1098-1104.
5. Hori, S., and S. Sakaguchi. 2004. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 6: 745-751.
6. Moritani, M., K. Yoshimoto, S. Ii, M. Kondo, H. Iwahana, T. Yamaoka, T. Sano, N. Nakano, H. Kikutani, and M. Itakura. 1996. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes: a gene therapy model for autoimmune diabetes. J. Clin. Invest. 98: 1851-1859.
7. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, et al. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185: 1711-1714.
8. Mathisen, P. M., M. Yu, J. M. Johnson, J. A. Drazba, and V. K. Tuohy. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186: 159-164.
9. Nakajima, A., C. M. Seroogy, M. R. Sandora, I. H. Tamer, G. L. Costa, C. Taylor-Edwards, M. H. Bachmann, C. H. Contag, and C. G. Fathman. 2001. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 107: 1293-1301.
10. Smith, R., I. H. Tamer, M. Hollenhorst, C. Lin, A. U. Levicnik, C. G. Fathman, and G. P. Nolan. 2003. Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis. Gene Ther. 10: 1248-1257.
11. Setoguchi, K., Y. Misaki, Y. Araki, K. Fujio, K. Kawahata, T. Kitamura, and K. Yamamoto. 2000. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J. Immunol. 165: 5980-5986.
12. Yamamoto, K., H. Sakoda, T. Nakajima, T. Kato, M. Okubo, M. Dohi, Y. Mizushima, K. Ito, and K. Nishioka. 1992. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int. Immunol. 4: 1219-1223.
13. Yamamoto, K., K. Masuko, S. Takahashi, Y. Ikeda, T. Kato, Y. Mizushima, K, Hayashi, and K. Nishioka. 1995. Accumulation of distinct T cell clonotypes in human solid tumors. J. Immunol. 154: 1804-1809.
14. + T cells by retroviral transfer of the TCR αβ-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte. J. Immunol. 171: 2154-2160.
15. Osman, G. E., M. Toda, O. Kanagawa, and L. E. Hood. 1993. Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J. Exp. Med. 177: 387-395.
16. Fujio, K., A. Okamoto, H. Tahara, M. Abe, Y. Jiang, T. Kitamura, S. Hirose, and K. Yamamoto. 2004. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease. J. Immunol. 173: 2118-2125.
17. Brady, G., and N. N. Iscove. 1993. Construction of cDNA libraries from single cells. Methods Enzymol. 225: 611-623.
18. Yu, R., K. Fujio, H. Tahara, Y. Araki, and K. Yamamoto. 2005. Clonal dynamics of tumor-infiltrating lymphocytes. Eur. J. Immunol. 35: 1754-1763.
19. Kalled, S. L., A. H. Cutler, and L. C. Burkly. 2001. Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment. J. Immunol. 167: 1740-1747.
20. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
21. Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305-312.
22. Fujio, K., Y. Misaki, K. Setoguchi, S. Morita, K. Kawahata, I. Kato, T. Nosaka, K. Yamamoto, and T. Kitamura. 2000. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the αβ TCR complex. J. Immunol. 165: 528-532.
23. Bokarewa, M., and A. Tarkowski. 2003. Local infusion of infliximab for the treatment of acute joint inflammation. Ann. Rheum. Dis. 62: 783-784.
24. Conti, F., R. Priori, M. S. Chimenti, G. Coari, A. Annovazzi, G. Valesini, and A. Signore. 2005. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Arthritis Rheum. 52: 1224-1226.
25. + regulatory T cells. Arthritis Rheum. 52: 2212-2221.
26. Yu, P., R. K. Gregg, J. J. Bell, J. S. Ellis, R. Divekar, H. H. Lee, R. Jain, H. Waldner, J. C. Hardaway, M. Collins, et al. 2005. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 174: 6772-6780.
27. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
28. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
29. + regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50: 2775-2785.
30. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172: 6435-6443.
31. Quattrocchi, E., M. J. Dallman, A. P. Dhillon, A. Quaglia, G. Bagnato, and M. Feldmann. 2001. Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J. Immunol. 166: 5970-5978.
32. Lubberts, E., M. I. Koenders, B. Oppers-Walgreen, L. van den Bersselaar, C. J. Coenen-de Roo, L. A. Joosten, and W. B. van den Berg. 2004. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50: 650-659.
33. Rubio-Godoy, V., V. Dutoit, Y. Zhao, R. Simon, P. Guillaume, R. Houghten, P. Romero, J. C. Cerottini, C. Pinilla, and D. Valmori. 2002. Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL. J. Immunol. 169: 5696-5707.